VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung

7680612970026 CH-61297 Pulver
VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung
VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung
VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/09/2021
Summary of Product Characteristics
Français
10/09/2021
Summary of Product Characteristics
Italien
10/09/2021
Patient information leaflet
Allemand
06/09/2021
Patient information leaflet
Français
06/09/2021
Patient information leaflet
Italien
06/09/2021

Detailed composition

Substance Quantity Type Category
PRC
400.0 U Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
12.15 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 2145.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2010

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
61297
Drug name
VPRIV, Pulver zur Herstellung einer Infusionslösung
Galenic form
PULPA
ATC Code
A16AB10
Authorization status
Z
Dispensing category
B
First authorization
29/08/2011
Authorization expiration date
31/12/9999
IT Number
07.14.0.
Domain
Human medicine
Field of application
Morbus Gaucher Typ 1

Package details

Description (FR)
VPRIV subst sèche 400 U flac
Description (DE)
VPRIV Trockensub 400 E Durchstf
Market launch
29/08/2011
Narcotic (BTM)
No

Other package sizes (1)

None
1 DUR
GTIN: None
Not in V1